IPO Profile: Nexvet Biopharma PLC

The Australia-based biopharma company went public on the Nasdaq in a $40 million offering

1 April 2015•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.